With the cytoactiv® test you may offer a major benefit to your senders: gynecologists are now in a position to inform their patients in a fast, clear and reliable way what the prognosis is for LSIL / HSIL.
The cytoactiv® test is designed to give patients more clarity whether the L1 capsid protein, which is necessary to stimulate the patient's self-healing powers, is present or not.
Demonstrate your diagnostic competence with our cytoactiv® test, which will provide the gynecologists and, of course, the patients with a fast and precise result.